150 related articles for article (PubMed ID: 33736628)
21. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400
[TBL] [Abstract][Full Text] [Related]
22. Trends in cervical cancer incidence and mortality in Oklahoma and the United States, 1999-2013.
Gopalani SV; Janitz AE; Campbell JE
Cancer Epidemiol; 2018 Oct; 56():140-145. PubMed ID: 30176544
[TBL] [Abstract][Full Text] [Related]
23. Immigration, screening, and cervical cancer incidence: an application of Age-Period-Cohort analysis.
Bucchi D; Chiavarini M; Bianconi F; Galeotti ME; Gili A; Stracci F
Eur J Cancer Prev; 2019 Nov; 28(6):529-536. PubMed ID: 30431461
[TBL] [Abstract][Full Text] [Related]
24. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
25. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
26. Trends in incidence and mortality risk for acromegaly in Norway: a cohort study.
Falch CM; Olarescu NC; Bollerslev J; Dekkers OM; Heck A
Endocrine; 2023 Apr; 80(1):152-159. PubMed ID: 36525222
[TBL] [Abstract][Full Text] [Related]
27. Trends in acute myocardial infarction event rates and risk of recurrences after an incident event in Norway 1994 to 2009 (from a Cardiovascular Disease in Norway Project).
Sulo G; Vollset SE; Nygård O; Igland J; Egeland GM; Ebbing M; Tell GS
Am J Cardiol; 2014 Jun; 113(11):1777-81. PubMed ID: 24746031
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: a population-based study.
Šavrova A; Jaal J; Nõmm O; Innos K
Public Health; 2023 Dec; 225():369-375. PubMed ID: 37989009
[TBL] [Abstract][Full Text] [Related]
29. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
30. [Cervical cancer after 10 years of nationally coordinated screening].
Haldorsen T; Skare GB; Steen R; Thoresen SO
Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
[TBL] [Abstract][Full Text] [Related]
31. Recent global burden of cervical cancer incidence and mortality, predictors, and temporal trends.
He WQ; Li C
Gynecol Oncol; 2021 Dec; 163(3):583-592. PubMed ID: 34688503
[TBL] [Abstract][Full Text] [Related]
32. Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia III.
Rapiti E; Usel M; Neyroud-Caspar I; Merglen A; Verkooijen HM; Vlastos AT; Pache JC; Kumar N; Bouchardy C
Eur J Cancer; 2012 Apr; 48(6):845-52. PubMed ID: 21658934
[TBL] [Abstract][Full Text] [Related]
33. Cervical Cancer Stage at Diagnosis and Survival among Women ≥65 Years in California.
Cooley JJP; Maguire FB; Morris CR; Parikh-Patel A; Abrahão R; Chen HA; Keegan THM
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):91-97. PubMed ID: 36620897
[TBL] [Abstract][Full Text] [Related]
34. Regional differences in cervical cancer incidence and associated risk behaviors among Norwegian women: a population-based study.
Hansen BT; Campbell S; Nygård M
BMC Cancer; 2021 Aug; 21(1):935. PubMed ID: 34412617
[TBL] [Abstract][Full Text] [Related]
35. Overall survival and time trends in breast and cervical cancer incidence and mortality in the Regional Health District (RHD) of Barretos, São Paulo, Brazil.
da Costa AM; Hashim D; Fregnani JHTG; Weiderpass E
BMC Cancer; 2018 Nov; 18(1):1079. PubMed ID: 30404614
[TBL] [Abstract][Full Text] [Related]
36. Incidence rates and temporal trends of cervical cancer relating to opportunistic screening in two developed metropolitan regions of Brazil: a population-based cohort study.
Teixeira JC; Maestri CA; Machado HDC; Zeferino LC; Carvalho NS
Sao Paulo Med J; 2019; 137(4):322-328. PubMed ID: 31691764
[TBL] [Abstract][Full Text] [Related]
37. Cervical Cancer Incidence Among Elderly Women in Massachusetts Compared With Younger Women.
Feldman S; Cook E; Davis M; Gershman ST; Hanchate A; Haas JS; Perkins RB
J Low Genit Tract Dis; 2018 Oct; 22(4):314-317. PubMed ID: 30256336
[TBL] [Abstract][Full Text] [Related]
38. Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study.
Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
BMJ Open; 2016 Aug; 6(8):e011981. PubMed ID: 27515759
[TBL] [Abstract][Full Text] [Related]
39. [In situ and invasive cervical cancer epidemiology in the province of Girona, Spain 1990-2004: incidence, mortality, survival and screening history].
Castro Marqueta P; Moreno-Crespi J; Buxó-Pujolràs M; Cervantes-Amat M; Pérez-Gómez B; Marcos-Gragera R
Med Clin (Barc); 2011 Feb; 136(5):192-8. PubMed ID: 21051058
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
